Henry Meds vs Remedy Meds: Eligibility and Medication

This article belongs to the PlexusDx Education Hub, our evidence-based reading on GLP-1 medications, weight management protocols, and the genetics that shape them. Browse all Peptides & GLP-1 education

This is independent editorial commentary. PlexusDx has no commercial relationship with Henry Meds or Remedy Meds, uses no affiliate links, and receives no compensation for naming either brand.

Full head-to-head: PlexusDx vs Henry Meds →

Full head-to-head: PlexusDx vs Remedy Meds →

The question behind "Henry Meds vs Remedy Meds meds" usually starts with eligibility: will I qualify, and what medication can I actually get? This editorial focuses on how each program screens patients and routes GLP-1 medication, then turns to the genetic variable neither company evaluates. As of April 2026 the market is large; we keep to these two brands.

Eligibility comes before medication

Before any GLP-1 is dispensed, both Henry Meds and Remedy Meds run a clinical gate: an intake that captures weight, medical history, and current medications, reviewed by a licensed provider. Meeting that eligibility threshold, not simply signing up, is what unlocks a prescription. The details of who qualifies can differ between programs.

How Remedy Meds screens and dispenses

Remedy Meds operates as telehealth paired with a compounded-pharmacy pathway. A provider reviews the intake and, if criteria are met, prescribes; a licensed compounding pharmacy fills it. Eligibility rules, medication options, and pricing vary and change, so check Remedy Meds's official website for current terms.

How Henry Meds screens and dispenses

Henry Meds likewise combines virtual evaluation with compounded dispensing, routing brand-name FDA-approved GLP-1 products or compounded semaglutide and tirzepatide through licensed pharmacies once eligibility is confirmed. See Henry Meds's official website for current criteria.

What can affect eligibility and access cost

Eligibility typically hinges on clinical factors reviewed at intake, and access cost follows from the medication and plan you qualify for. In the 2026 GLP-1 telehealth market, monthly totals commonly fall between roughly $200 and $700 or more once program fees, medication, and compounded dispensing are counted. Because Henry Meds and Remedy Meds publish their own eligibility terms and rates, verify both directly on each brand's site before deciding.

Eligibility aside, the compound drives the effect

Qualifying for a program does not change the pharmacology, which comes from the molecule. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide act on appetite, satiety, and gastric emptying. The trials studied compounds: STEP for semaglutide in weight management (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024). Outcomes vary by dose, compound, and person.

The eligibility factor no intake screens for

No intake form weighs the inherited biology a GLP-1 drug will meet, even though it shapes the response. FTO influences fat-mass and obesity risk, MC4R anchors satiety and energy balance, GLP1R encodes the receptor GLP-1 compounds target, and TCF7L2 connects to glucose regulation and GLP-1 secretion. These pathway-level variants describe biology, not a predicted response. PlexusDx pairs its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — with the Precision Peptide Genetic Test, which reads 14 pathways, 49 peptides, 150+ genetic insights across FTO, MC4R, and TCF7L2. That is test before you invest: understand your baseline, then bring it to your provider.

Not affiliated: PlexusDx has no affiliation with Henry Meds or Remedy Meds and no commercial tie to any company reviewed here.

Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.

Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds or Remedy Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

See where PlexusDx fits: review the Weight Management Protocols or start with the Precision Peptide Genetic Test.

Frequently Asked Questions

Who is eligible for Henry Meds or Remedy Meds?

Both programs determine eligibility through a clinical intake reviewed by a licensed provider, weighing weight, medical history, and current medications. Specific thresholds differ and can change. Neither guarantees a prescription simply for enrolling; qualification depends on the provider's review. Check each brand's current criteria on its own site.

Can I get compounded medication from either program?

Both Henry Meds and Remedy Meds can route compounded semaglutide or tirzepatide through licensed compounding pharmacies, or brand-name products, depending on eligibility and availability. The pharmacy pathway is decided during intake. Confirm which formulation each program offers, and to whom, on its own website before enrolling.

Does the Precision Peptide Genetic Test affect my eligibility?

No. It plays no part in program eligibility and does not predict response to any compound or to Henry Meds or Remedy Meds. It reports pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline GLP-1 biology — context for your provider conversation.

How does PlexusDx compare on access?

PlexusDx dispenses semaglutide and tirzepatide through its Weight Management Protocols and pairs them with the Precision Peptide Genetic Test. The distinguishing feature is upstream genetic context on FTO, MC4R variants, which eligibility-gated programs like Henry Meds and Remedy Meds do not provide alongside the medication.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education